197 related articles for article (PubMed ID: 37489761)
1. Advances in isothermal nucleic acid amplification methods for hepatitis B virus detection.
Li H; Song W; Li H; Cui J; Xie Y; Wu B; Chen R
Analyst; 2023 Aug; 148(16):3708-3718. PubMed ID: 37489761
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in molecular diagnostics of hepatitis B virus.
Datta S; Chatterjee S; Veer V
World J Gastroenterol; 2014 Oct; 20(40):14615-25. PubMed ID: 25356025
[TBL] [Abstract][Full Text] [Related]
3. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
4. Detection of Hepatitis B Virus DNA among Chronic and potential Occult HBV patients in resource-limited settings by Loop-Mediated Isothermal Amplification assay.
Akram A; Islam SMR; Munshi SU; Tabassum S
J Viral Hepat; 2018 Nov; 25(11):1306-1311. PubMed ID: 29768691
[TBL] [Abstract][Full Text] [Related]
5. An ultra-sensitive Abbott ARCHITECT
Lou S; Taylor R; Pearce S; Kuhns M; Leary T
J Clin Virol; 2018 Aug; 105():18-25. PubMed ID: 29843004
[TBL] [Abstract][Full Text] [Related]
6. Development of sensitive and specific loop-mediated isothermal amplification combined with lateral flow device for the rapid detection of hepatitis B virus infection.
Maity SN; Poonati R; Punati RD; Mallepaddi P; Marothi Y; Mallepaddi PC
Braz J Microbiol; 2022 Jun; 53(2):615-623. PubMed ID: 35178681
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas12b assisted loop-mediated isothermal amplification for easy, rapid and sensitive quantification of chronic HBV DNA in one-pot.
Xu H; Lin G; Chen R; Cai Z; Sun Y; Zhang X; Zhao B; Zeng Y; Liu J; Liu X
Anal Chim Acta; 2024 Jun; 1310():342702. PubMed ID: 38811141
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
Kiely P; Margaritis AR; Seed CR; Yang H;
Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
[TBL] [Abstract][Full Text] [Related]
9. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
10. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
Kuhns MC; Holzmayer V; Anderson M; McNamara AL; Sauleda S; Mbanya D; Duong PT; Dung NTT; Cloherty GA
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696483
[TBL] [Abstract][Full Text] [Related]
11. Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay.
Tsoi WC; Lelie N; Lin CK
Transfusion; 2013 Oct; 53(10 Pt 2):2477-88. PubMed ID: 23521050
[TBL] [Abstract][Full Text] [Related]
12. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
Japanese Red Cross NAT Screening Research Group
Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
[TBL] [Abstract][Full Text] [Related]
13. Field applicable detection of hepatitis B virus using internal controlled duplex recombinase-aided amplification assay and lateral flow dipstick assay.
Bai X; Ma X; Li M; Li X; Fan G; Zhang R; Wang R; Duan Q; Shen X; Xie Y; Rong X
J Med Virol; 2020 Dec; 92(12):3344-3353. PubMed ID: 32190907
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections.
Vermeulen M; Coleman C; Mitchel J; Reddy R; van Drimmelen H; Ficket T; Lelie N
Transfusion; 2013 Oct; 53(10 Pt 2):2459-66. PubMed ID: 23621791
[TBL] [Abstract][Full Text] [Related]
15. Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing.
Lelie N; Bruhn R; Busch M; Vermeulen M; Tsoi WC; Kleinman S;
Transfusion; 2017 Jan; 57(1):24-35. PubMed ID: 27673757
[TBL] [Abstract][Full Text] [Related]
16. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?
Dodd RY; Nguyen ML; Krysztof DE; Notari EP; Stramer SL
Transfusion; 2018 Sep; 58(9):2166-2170. PubMed ID: 30144082
[TBL] [Abstract][Full Text] [Related]
17. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.
Yoshikawa A; Gotanda Y; Itabashi M; Minegishi K; Kanemitsu K; Nishioka K;
Vox Sang; 2005 Feb; 88(2):77-86. PubMed ID: 15720604
[TBL] [Abstract][Full Text] [Related]
18. Rapid detection of hepatitis B virus in blood plasma by a specific and sensitive loop-mediated isothermal amplification assay.
Nyan DC; Ulitzky LE; Cehan N; Williamson P; Winkelman V; Rios M; Taylor DR
Clin Infect Dis; 2014 Jul; 59(1):16-23. PubMed ID: 24704724
[TBL] [Abstract][Full Text] [Related]
19. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
van de Laar TJ; Hogema BM; Molenaar-de Backer MW; Marijt-van der Kreek T; Zaaijer HL
Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
[TBL] [Abstract][Full Text] [Related]
20. Molecular characteristics of HBV infection among blood donors tested HBsAg reactive in a single ELISA test in southern China.
Ye X; Li T; Li R; Liu H; Zhao J; Zeng J
BMC Infect Dis; 2021 Jan; 21(1):83. PubMed ID: 33468062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
